BACE1 and early-onset autosomal dominant Alzheimer disease: The inhibition of BACE1 can reduce β-amyloid generation and has therefore been extensively studied as a potential therapeutic strategy for Alzheimer’s disease and related neurodegenerative disorders (Cole and Vassar 2007).